Sciformix Corporation

Activities: Regulatory

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Regulatory

The future of pharmacovigilance and the impact of automation

Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. David J. Balderson, Vice President, Global Safety Operations, Sciformix, a Covance company, reports
Digital

Sciformix Corporation and Cambridge Semantics partnership

This partnership will enable safety organisations to reduce timelines, increase quality and glean enhanced insights for effective scientific data management
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

EudraVigilance: what’s changed?

In May 2017, the updates to the EudraVigilance system were approved for release and the changes went into effect on 22 November 2017, implemented by the European Medicines Agency (EMA)
Media

Automated and integrated drug safety database solution

Through its collaboration with Oracle Health Sciences, Sciformix is able to offer its customers a fully automated and integrated safety database solution, allowing easy reporting and analytics for improving the quality and efficiency of drug safety operations
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Labelling and generics: who is accountable?

Bindu Narang, Director of Regulatory Affairs and Scientific Writing, Sciformix Corporation, considers the impact of proposed US FDA labelling regulations on the generic drugs sector
Digital

Sciformix names Fran Bates as VP of Technology Services

Appointment supports customer needs and future growth by offering technology services solutions focused on science
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Creating proactive productvigilance systems

In addition to proof of drug effectiveness, pharmacovigilance has become an important safety requirement laid down by the regulators. Dr Chitra Lele, CSO, Sciformix Corporation, discusses the importance of establishing an effective global safety framework to meet today’s needs
Subscribe now